期刊文献+
共找到39篇文章
< 1 2 >
每页显示 20 50 100
过敏性鼻炎患儿血清HLA-G、Claudin-1水平变化及与病情严重程度的关系
1
作者 李娟 胡广成 +3 位作者 陈欢欢 王昕 董晓莎 曹焕珍 《国际检验医学杂志》 CAS 2024年第8期955-958,共4页
目的 探讨过敏性鼻炎患儿血清人类白细胞抗原G(HLA-G)、封闭蛋白1(Claudin-1)水平的变化及其与病情严重程度的关系。方法 选取该院2021年7月1日至2022年7月1日收治的86例过敏性鼻炎患儿作为观察组,同期在该院体检的34例健康儿童作为对... 目的 探讨过敏性鼻炎患儿血清人类白细胞抗原G(HLA-G)、封闭蛋白1(Claudin-1)水平的变化及其与病情严重程度的关系。方法 选取该院2021年7月1日至2022年7月1日收治的86例过敏性鼻炎患儿作为观察组,同期在该院体检的34例健康儿童作为对照组。采用酶联免疫吸附试验检测两组血清HLA-G、Claudin-1水平并进行比较。比较治疗前及治疗过程中观察组患儿过敏性鼻炎症状量表(SFAR)和伴随症状的视觉模拟量表(VAS)评分,分析不同SFAR、VAS评分患儿血清HLA-G、Claudin-1水平。采用Spearman法分析血清HLA-G、Claudin-1水平与SFAR和VAS评分的相关性。结果 与对照组相比,观察组血清HLA-G水平较高,Claudin-1水平较低,差异均有统计学意义(P<0.05);观察组在治疗30周、1年后HLA-G水平明显降低,Claudin-1水平明显升高,差异均有统计学意义(P<0.05)。与治疗前比较,治疗30周、1年后观察组SFAR评分降低,VAS评分轻度/中重度比例减少,差异有统计学意义(P<0.05)。相关性分析结果显示,过敏性鼻炎患儿血清HLA-G水平与病情严重程度呈正相关(r_(SFAR)=0.433,P<0.05;r_(VAS)=0.442,P<0.05),Claudin-1水平与病情严重程度呈负相关(r_(SFAR)=-0.483,P<0.05;r_(VAS)=-0.468,P<0.05)。结论 过敏性鼻炎患儿血清HLA-G水平较高,Claudin-1水平较低,且与病情严重程度相关,二者具有作为诊断和评价疾病标志物的潜力。 展开更多
关键词 过敏性鼻炎 人类白细胞抗原g 封闭蛋白1 疾病标志物
下载PDF
Transient over-expression of human papillomavirus type 16 E6 protein down-regulate the secretion of TNF-αor IL-1β LPS-induced from macrophages
2
作者 CHUN LIAN CHEN YI MOU WU +4 位作者 YONG LIN JIANG CUI MING ZHU XIN WANG JUN PENG YAN PING WAN 《Journal of Microbiology and Immunology》 2007年第1期52-56,共5页
In order to provide the experimental basis for the further studies on the oncogenic mechanism of the E6 protein from human papillomavirus type 16 (HPV16), the eukaryotic expression vector pcDNA3.1 (-)/E6 was used ... In order to provide the experimental basis for the further studies on the oncogenic mechanism of the E6 protein from human papillomavirus type 16 (HPV16), the eukaryotic expression vector pcDNA3.1 (-)/E6 was used for the study on the effect of E6 protein to influence the secretory activity of LPS-induced 3MP-1-macrophages, and the reconstructed plasmid pcDNA3.1 (-)/E6 was transfected into THP-1-macrophages. The expression of E6 gene was assayed in macrophage lysates by using Western blot analysis and the level of TNF-α or IL-1β was examined by ELISA. All of data were analyzed by SPSS12.0. As demonstrated by Western blot analysis, the expression of E6 protein with a molecular weight of about 18 kDa by plasmid pcDNA3.1 (-)/E6 in THP-1-macrophages could be detected. However, as demonstrated by ELISA assay, the level of TNF-α or IL-1β in lysates of THP-1-macrophages showed an obvious difference between the pcDNA3.1 (-)/E6 group and the LPS control group or the pcDNA3.1 (-) control group (P 〈 0.01), but no significant difference existed between pcDNA3.1 (-) control group and LPS control group ( P 〉 0.05). All these results illustrate that the transient over-expression of HPV6 E6 protein reduces the production of TNF-α and IL-1β induced by LPS in THP-1-macrophages. 展开更多
关键词 human papillomavirus type 16 (hpv16) E6 Macrophages TNF-α IL-1β
下载PDF
低氧下沉默HLA-G对JEG-3细胞、EPAS1表达及其生物学行为的影响
3
作者 孙春蕾 杨娟 +3 位作者 谢莹莺 许文宇 雷娟 刘朵朵 《安徽医科大学学报》 CAS 北大核心 2023年第1期47-53,共7页
目的探讨在低氧条件下,沉默绒毛膜滋养细胞系JEG-3细胞的人类白细胞相关抗原-G(HLA-G)表达对JEG-3细胞生物学功能的影响和通过内皮PAS1区域蛋白1(EPAS1)低氧反应通路参与高原低氧条件下子痫前期发病的分子机制。方法通过转染小干扰RNA(s... 目的探讨在低氧条件下,沉默绒毛膜滋养细胞系JEG-3细胞的人类白细胞相关抗原-G(HLA-G)表达对JEG-3细胞生物学功能的影响和通过内皮PAS1区域蛋白1(EPAS1)低氧反应通路参与高原低氧条件下子痫前期发病的分子机制。方法通过转染小干扰RNA(siRNA)抑制JEG-3细胞中HLA-G的表达,将转染后的JEG-3细胞分为4组:常氧对照组、低氧对照组、常氧抑制组、低氧抑制组。采用CCK-8实验及体外侵袭实验法检测4组细胞的增殖及侵袭能力;用流式细胞术检测4组细胞凋亡和细胞周期的影响;通过qPCR技术及Western blot法检测4组细胞中HLA-G和EPAS1 mRNA及蛋白的表达水平。结果(1)与常氧对照组相比,低氧对照组及常氧、低氧抑制组均可使JEG-3细胞的增殖活性、侵袭能力降低,使得细胞凋亡率显著升高,低氧对照组与低氧抑制组产生了明显的坏死细胞群。低氧条件下,降低HLA-G的表达会提高细胞坏死率。无论在常氧还是低氧下,抑制HLA-G表达均使细胞被阻滞在G1期。(2)与常氧对照组相比,低氧对照组及常氧、低氧抑制组均降低HLA-G蛋白表达,且低氧和抑制HLA-G蛋白表达二者有协同作用,均可增加缺氧诱导因子-2α(HIF-2α)、血管内皮生长因子(VEGF)及内皮素-1(ET-1)蛋白表达,抑制HLA-G则降低诱导型一氧化氮合成酶(NOS2)的表达。结论低氧环境下,沉默HLA-G可能通过EPAS1低氧反应通路影响滋养细胞生物学行为,参与了子痫前期的发生发展。 展开更多
关键词 子痫前期 低氧 人类白细胞抗原g 内皮PAS1区域蛋白1 高海拔
下载PDF
Effects of Sterigmatocystin, Deoxynivalenol and Aflatoxin G_1 on Apoptosis of Human Peripheral Blood Lymphocytes in vitro 被引量:7
4
作者 SunXM等 ZhangXH 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2002年第2期145-152,共8页
Objective To explore the effects of Sterigmatocystin (ST), Deoxynivalenol (DON) and Aflatoxin G1 (AFG1) on apoptosis of human peripheral blood lymphocytes (HPBLs) in vitro and thus to further elucidate the putative r... Objective To explore the effects of Sterigmatocystin (ST), Deoxynivalenol (DON) and Aflatoxin G1 (AFG1) on apoptosis of human peripheral blood lymphocytes (HPBLs) in vitro and thus to further elucidate the putative roles of these three mycotoxins on human immunosystem. Methods The effects of ST, DON and AFG1 on apoptosis of HPBLs were studied with cell culture, flow cytometric (FCM) DNA analysis and DNA agarose gel electrophoresis. Results DNA agarose gel electrophoresis results showed the characteristic 'ladder' pattern of apoptosis in HPBLs treated with ST, DON and AFG1. Flow cytometric DNA analysis revealed that typical subdiploid peaks of apoptosis in DNA histogram could be seen in all groups treated with the three mycotoxins. Significant time-effect and dose-effect relationships were found between the apoptosis rates and treatment time as well as concentrations of the three mycotoxins. Conclusion ST, DON and AFG1 can induce apoptosis of HPBLs in vitro and may have some negative effects on human immunosystem. 展开更多
关键词 STERIgMATOCYSTIN DEOXYNIVALENOL Aflatoxin g1 APOPTOSIS human LYMPHOCYTES
下载PDF
RELATIONSHIP BETWEEN CYCLIN G1 AND HUMAN PAPILLOMA VIRUS INFECTION IN CERVICAL INTRAEPITHELIAL NEOPLASIA AND CERVICAL CARCINOMA 被引量:5
5
作者 Jing Liang Mei-lu Bian +4 位作者 Qing-yun Chen Xia Liu Hua Ou Min Li Jun Liu 《Chinese Medical Sciences Journal》 CAS CSCD 2006年第2期81-85,共5页
Objective To evaluate the overexpression of cyclin G1 in cervical intraepithelial neoplasia (CIN) and cervical carcinoma, and the correlation between cyclin G1 and high-risk human papilloma virus (HPV) infection. ... Objective To evaluate the overexpression of cyclin G1 in cervical intraepithelial neoplasia (CIN) and cervical carcinoma, and the correlation between cyclin G1 and high-risk human papilloma virus (HPV) infection. Methods All of the specimens were obtained from the Department of Pathology of China-Japan Friendship Hospital from January 2000 to August 2004. We detected the expression of cyclin G1 with immunohistochemistry, HPV16/18 infection with in situ hybridization, and high-risk HPV infection with Hybrid capture system Ⅱ (HC-Ⅱ) in normal group (25 cases), CIN Ⅰ (48 cases), CIN Ⅱ (56 cases), CIN Ⅲ(54 cases), and invasive cervical squamous-cell carcinoma (SCC, 31 cases). Results The positive rates of cyclin G1 expression in CIN(77.85% )and SCC cervical tissues (87. 10% ) were significantly higher than normal ( 8.00%, P 〈 0. 01 ), and the intensities of cyclin G1 expression in CIN(40. 60% ) and SCC cervical tissues (61.51%) were significantly higher than normal (2. 72%, P 〈0.05). The positive rates and intensities of cyclin G1 expression increased gradually with the grade of cervical lesions. High-risk HPV infection rates were higher in CIN and SCC than normal groups (P 〈 0.05 ). There was a positive correlation between cyclin G1 expression and high-risk HPV infection detected with HC-Ⅱ (Kendall's tau-b =0. 316, 0. 269, 0. 352, and 0. 474 in CIN Ⅰ, CIN Ⅱ, CIN Ⅲ, and SCC, respectively, P 〈 0. 05 ). Conclusions Cyclin G1 is overexpressed in CIN and SCC. Cyclin G1 may be a biomarker for detecting CIN and SCC. Cyclin G1 may play an important role in the oncogenesis of CIN and SCC by high-risk HPV infection. 展开更多
关键词 cyclin g1 human papilloma virus cervical intraepithelial neoplasia cervical squamouscell carcinoma IMMUNOHISTOCHEMISTRY in situ hybridization Hybrid capture system
下载PDF
Down-Modulation of Notch1 Expression in Cervical Cancer Is Associated with HPV-Induced Carcinogenesis
6
作者 Li Sun Yongmei Song +3 位作者 Tong Tong Lingying Wu Wenhua Zhang Qimin Zhan 《Clinical oncology and cancer researeh》 CAS CSCD 2009年第6期401-405,共5页
OBJECTIVE Notch1 signaling has been implicated intumorigenesis. The purpose of this study was to investigate theputative role of the Notch1 receptor in carcinogenesis and in theprogression of the cervical cancer. Sinc... OBJECTIVE Notch1 signaling has been implicated intumorigenesis. The purpose of this study was to investigate theputative role of the Notch1 receptor in carcinogenesis and in theprogression of the cervical cancer. Since human papillomavirus(HPV) is a causative agent in cervical carcinoma, the interactionbetween Notch1 and HPV infection was examined.METHODS Forty cervical cancer samples and 30 normalcervical tissue specimens were examined using Western blot andRT-PCR to detect Notch1 protein and mRNA levels. HPV16 DNAwas examined in all samples using PCR.RESULTS The level of Notch1 protein expression wassignificantly lower in cervical cancer tissue than in normal tissue.Levels of Notch1 mRNA were found to be substantially downregulatedin cancer tissue. Notch1 protein expression levelswere significantly higher in carcinomas without HPV DNAthan that in carcinomas with HPV infection (55.5% vs. 3.3%, P <0.05). Down-modulation of Notch1 mRNA levels in carcinomawas demonstrated to be associated with HPVE6 transcription.Moreover, levels of Notch1 expression were shown to besignificantly higher in early stage disease than in advanced stagedisease (P = 0.001).CONCLUSION Down-modulation of Notch1 expressionprobably plays an important role in the late stages of HPVinducedcervical cancer. 展开更多
关键词 cervical cancer NOTCH1 human papillomavirus (hpv).
下载PDF
Polymorphism of Human Organic Cationic Transporter1 (C480G) in Egyptian Chronic Myeloid Leukemia Patients on Imatinib
7
作者 Nahla A. M. Hamed Hashim Neanea +2 位作者 Amal M. Ghanem Maha M. A. Elgammal Yasmen Samir 《American Journal of Molecular Biology》 2018年第2期83-91,共9页
Background: Human organic cationic transporter1 (Hoct1) is a plasma membrane transporter responsible for the main influx of Imatinib into chronic myeloid leukemia (CML) cells. Single nucleotide polymorphisms (SNPs) in... Background: Human organic cationic transporter1 (Hoct1) is a plasma membrane transporter responsible for the main influx of Imatinib into chronic myeloid leukemia (CML) cells. Single nucleotide polymorphisms (SNPs) in the gene coding for hOCT1 are important factors causing Imatinib resistance. We investigated the frequency of hOCT1 SNP C480G among Egyptian CML patients and its relation to early molecular response as an indicator of treatment outcome. Materials and Methods: Two groups of CML patients were included in this study. Group I consisted of 25 patients responding to Imatinib treatment (Imatinib responsive) and group II consisted of 25 patients resistant to Imatinib (Imatinib resistant). Response criteria were assessed according to the NCCN (National Comprehensive Cancer Network) guidelines 2017. Twenty healthy controls of matched age and sex were also included (group III). For all patients, we studied hOCT1 C480G at initial presentation using Taqman drug metabolism genotyping as well as BCR-ABL percent at diagnosis and after 3 months interval. Results: hOCT1 C480G was present in 32% of studied CML patients. CC (wild) was detected in 68% of group I and 64% of group II. CG (mutant heterozygous) was present in 28% of group I and 36% of group II while GG (mutant homozygous) was detected in only one case in group I. CG was also detected in 15% of control subjects There was no significant difference between hOCT1 C480G polymorphism and Early Molecular Response (χ2 = 0.089, p = 0.765). Conclusions: hOCT1 C480G polymorphism has no association with Imatinib resistance in Egyptian population. However, further studies on a larger number of patients are still needed to confirm this finding. 展开更多
关键词 Chronic MYELOID LEUKEMIA IMATINIB EgYPTIAN Resistance human Organic CATIONIC Transporter1 C480g POLYMORPHISM
下载PDF
子痫前期患者血清HLA-G、TGF-β1、sFlt-1水平变化及预测价值分析 被引量:6
8
作者 张凡 郭睿 +1 位作者 辛德梅 邓春霞 《解放军医药杂志》 CAS 2022年第6期72-75,共4页
目的探讨子痫前期患者血清人类白细胞抗原-G(HLA-G)、转化生长因子-β1(TGF-β1)及可溶性血管内皮生长因子受体-1(sFlt-1)水平变化,并分析三项指标对子痫前期孕妇的预测价值。方法收集2016年4月—2020年4月在本院治疗的109例子痫前期孕... 目的探讨子痫前期患者血清人类白细胞抗原-G(HLA-G)、转化生长因子-β1(TGF-β1)及可溶性血管内皮生长因子受体-1(sFlt-1)水平变化,并分析三项指标对子痫前期孕妇的预测价值。方法收集2016年4月—2020年4月在本院治疗的109例子痫前期孕妇临床资料(轻度子痫63例、重度子痫46例),并设为观察组,另选取同期在本院孕检的正常妊娠孕妇86例作为对照组。对比2组及不同程度子痫前期孕妇HLA-G、TGF-β1及sFlt-1水平,采用多因素Logistic回归分析探讨孕妇子痫前期发生的危险因素,采用受试者工作特征(ROC)曲线分析HLA-G、TGF-β1及sFlt-1联合检测对孕妇子痫前期发生的预测价值。结果观察组HLA-G低于对照组,TGF-β1、sFlt-1高于对照组(P<0.01)。重度子痫孕妇HLA-G低于轻度子痫孕妇,TGF-β1、sFlt-1高于轻度子痫孕妇(P<0.01)。多因素Logistic回归分析显示,妊娠期高血压病、妊娠期糖尿病、HLA-G降低、TGF-β1升高、sFlt-1升高为孕妇子痫前期发生的独立危险因素(P<0.05)。HLA-G、TGF-β1及sFlt-1联合检测预测孕妇子痫前期发生的敏感度、特异度、曲线下面积均高于单一指标检测。结论临床可对孕妇加强HLA-G、TGF-β1及sFlt-1水平监测,三项指标联合检测对孕期子痫前期发生有较大的预测价值。 展开更多
关键词 子痫 孕妇 人类白细胞抗原-g 转化生长因子-Β1 可溶性血管内皮生长因子受体-1 预测价值
下载PDF
单纯疱疹病毒I型Stocker株糖蛋白G基因在PBV221原核表达载体的表达与纯化 被引量:1
9
作者 刘毅 韩金祥 +2 位作者 朱波 王世立 张更林 《山东大学学报(医学版)》 CAS 北大核心 2005年第6期473-477,共5页
目的:构建I型单纯疱疹病毒型特异性包膜糖蛋白G基因片段的表达载体,进行原核表达,并纯化目的蛋白。方法:用PCR法扩增HSV1-gG强抗原决定簇的基因片段,将该段基因克隆于PBV221表达载体,转化大肠杆菌DH5α,温控诱导目的蛋白表达,表达产物... 目的:构建I型单纯疱疹病毒型特异性包膜糖蛋白G基因片段的表达载体,进行原核表达,并纯化目的蛋白。方法:用PCR法扩增HSV1-gG强抗原决定簇的基因片段,将该段基因克隆于PBV221表达载体,转化大肠杆菌DH5α,温控诱导目的蛋白表达,表达产物以包涵体形式存在,用SDS-PAGE和Westernblot鉴定目的蛋白,经离子交换纯化获得较纯的目的蛋白。结果:获得了重组的原核表达载体及相对分子质量为14.7kD的重组蛋白,并纯化获得了纯度大于90%的目的蛋白抗原。结论:成功克隆和表达了高纯度的HSV1-gG蛋白。 展开更多
关键词 单纯疱疹病毒Ⅰ型 包膜糖蛋白g 重组蛋白质类 基因表达
下载PDF
人可溶性sTNFR1及胞膜外区Ig融合基因重组腺病毒的真核表达及功能活性鉴定
10
作者 马佳佳 Nick Lu 陈必良 《中国药理学通报》 CAS CSCD 北大核心 2013年第8期1098-1103,共6页
目的构建携带人sTNFR1与IgGFc片段融合基因的重组腺病毒,稳定表达并初步鉴定其功能活性在妊娠哮喘炎症机制中的作用。方法将PCR扩增的sTNFR1及IgGFc基因片段先后连接到穿梭质粒pAdTrack-CMV多克隆位点上,酶切线性化后在BJ5183细菌内与... 目的构建携带人sTNFR1与IgGFc片段融合基因的重组腺病毒,稳定表达并初步鉴定其功能活性在妊娠哮喘炎症机制中的作用。方法将PCR扩增的sTNFR1及IgGFc基因片段先后连接到穿梭质粒pAdTrack-CMV多克隆位点上,酶切线性化后在BJ5183细菌内与骨架质粒pAdEasy-1同源重组,产生获得的AdE-EGFP-sTNFR1-Ig以脂质体法转染AD293细胞进行病毒包装,以绿色荧光蛋白(GFP)监测病毒滴度及感染效率。RT-PCR、Western blot实验鉴定细胞内重组腺病毒转录及融合基因与蛋白表达;流式细胞术、ELISA实验分析混合培养上清中转染肥大细胞(MC)激活、调节同基因来源T细胞表达Th2/Treg水平及细胞因子分泌效果;MTT评估转染细胞上清中sTNFR1-Ig对TNF-α介导细胞毒效应的拮抗作用。结果成功构建编码sTNFR1-Ig基因的重组腺病毒载体经酶切和测序鉴定正确,制备的腺病毒在转染细胞中的GFP表达以及CPE效应明显,扩增后的滴度为3.7×1010~4.8×1010pfu/ml,体外感染效率可达90%以上;sTNFR1-Ig基因在mRNA及蛋白水平获得的清晰条带均证实腺病毒包装与扩增成功。表达sTNFR1-Ig的MC诱导T细胞转化为CD4+CD25+Foxp3+T细胞水平以及IL-12含量均明显升高,CD4+IL-4+Th2细胞水平下调(P<0.05),Th2/Treg所占CD4+T细胞比值下降(P<0.05)。sTNFR1-Ig封闭TNF-α对MC免疫毒性作用的浓度效应明显,而EGFP-MCs与对照细胞上清对TNF-α毒性效应的中和阻断能力不足(P<0.05)。结论携sTNFR1-Ig基因重组腺病毒参与的免疫调控与妊娠期哮喘发生发展密切相关。sTNFR1及IgG-Fc亚基胞膜外区结合的表达和引起免疫耐受的作用研究,为妊娠哮喘发病机制在理论上的新突破,为以sTNFRI-Ig为靶点的妊娠哮喘干预治疗奠定基础。 展开更多
关键词 人可溶性TNF受体1 免疫球蛋白g 哮喘 妊娠 腺病毒 真核表达
下载PDF
低氧环境下HLA-G及EPAS1参与大鼠子痫前期发病机制研究
11
作者 谢莹莺 马萌 +4 位作者 赵海宁 徐梦婷 何岑盈 孙春蕾 许文宇 《安徽医科大学学报》 CAS 北大核心 2022年第9期1436-1441,共6页
目的探讨低氧对孕鼠胎盘组织人类白细胞抗原-G(HLA-G)及内皮PAS结构域包含蛋白1(EPAS1)的影响及参与子痫前期发病机制研究。方法将SD孕鼠随机分为常氧组,急性低氧组:48 h、72 h、1周组,慢性低氧组:2周、3周组,共6组;通过腹腔注射亚硝基... 目的探讨低氧对孕鼠胎盘组织人类白细胞抗原-G(HLA-G)及内皮PAS结构域包含蛋白1(EPAS1)的影响及参与子痫前期发病机制研究。方法将SD孕鼠随机分为常氧组,急性低氧组:48 h、72 h、1周组,慢性低氧组:2周、3周组,共6组;通过腹腔注射亚硝基左精氨酸甲酯(L-NAME)溶液建立子痫前期模型。运用无创血压仪测量孕鼠鼠尾动脉血压,全自动生化分析仪检测孕鼠血清丙氨酸氨基转移酶(ALT)、白蛋白(ALB)、尿素氮(BUN)、肌酐(Cr)值及尿蛋白值,免疫组化检测孕鼠胎盘HLA-G蛋白及EPAS1蛋白表达情况。结果①各子痫前期组孕鼠平均收缩压、平均舒张压及妊娠21 d尿蛋白均高于同条件正常妊娠孕鼠,差异有统计学意义(P<0.05),而低氧对孕鼠血压及尿蛋白无影响。②低氧环境下,孕鼠ALT、BUN值均发生改变,其中正常妊娠、子痫前期组孕鼠ALT、BUN值均在低氧72 h后开始上升,低氧1周升高达最大值,低氧3周下降,但仍比常氧组稍高(P<0.05)。③各子痫前期组与同条件正常妊娠组孕鼠比较,HLA-G蛋白表达阳性率均下降,差异有统计学意义(P<0.05);低氧亦影响孕鼠HLA-G蛋白表达阳性率,HLA-G蛋白阳性率整体呈先下降后上升的动态变化。④各子痫前期组与同条件正常妊娠组孕鼠比较,EPAS1蛋白表达阳性率均上升,差异有统计学意义(P<0.05);低氧亦影响孕鼠EPAS1蛋白表达阳性率,EPAS1蛋白阳性率整体呈先上升后下降的动态变化。结论低氧环境下孕鼠胎盘HLA-G蛋白整体表达呈先下降后上升的动态变化,急性低氧可能加重母体对胎盘产生免疫攻击性,但在机体适应低氧后,母体和胎盘免疫关系又恢复正常;EPAS1蛋白整体表达呈先上升后下降的动态变化,EPAS1对缺氧的高选择性压力的反应,可能引起对于高原缺氧的习服适应。 展开更多
关键词 低氧环境 大鼠 子痫前期 人类白细胞抗原-g 内皮PAS结构域包含蛋白1
下载PDF
子宫内膜异位症患者血清PAI-1、sHLA-G、MMIF表达及临床诊断 被引量:6
12
作者 姚红 黄树峰 武艳玲 《中国计划生育学杂志》 2021年第7期1431-1434,共4页
目的:探讨子宫内膜异位症(Ems)患者血清纤溶酶原激活物抑制因子-1(PAI-1)、可溶性人类白细胞抗原-G(sHLA-G)、巨噬细胞移动抑制因子(MMIF)表达及临床诊断意义。方法:选择2019年1月-2020年6月本院接诊的Ems患者68例为Ems组,同期体检健康... 目的:探讨子宫内膜异位症(Ems)患者血清纤溶酶原激活物抑制因子-1(PAI-1)、可溶性人类白细胞抗原-G(sHLA-G)、巨噬细胞移动抑制因子(MMIF)表达及临床诊断意义。方法:选择2019年1月-2020年6月本院接诊的Ems患者68例为Ems组,同期体检健康妇女65例为对照组,分析两组血清PAI-1、sHLA-G、MMIF水平,采用受试者工作特征曲线(AUC)分析血清PAI-1、sHLA-G、MMIF诊断Ems价值。结果:Ems组血清PAI-1(193.56±61.68 mg/L)、sHLA-G(10.68±1.74μg/L)、MMIF(2.01±0.42 ng/ml)水平高于对照组,且Ⅱ期<Ⅲ期<Ⅳ期患者,轻度痛经<中度痛经<重度痛经患者(均P<0.05);预测子宫内膜异位症的AUC,PAI-1为0.983,95%CI为0.935~1.000;sHLA-G为0.986,95%CI为0.975~0.993,MMIF为0.981,95%CI为0.959~0.992;3项联合检测(0.996,95%CI为0.993~1.000)高于单独检测(P<0.05),此时特异度(93.2%)、准确度(94.3%)均高于单独检测。结论:在子宫内膜异位症患者中血清PAI-1、sHLA-G、MMIF的表达与不同分期、痛经程度存在密切关系,对子宫内膜异位症有较高预测价值。 展开更多
关键词 子宫内膜异位症 纤溶酶原激活物抑制因子-1 可溶性人类白细胞抗原-g 巨噬细胞移动抑制因子 诊断价值
下载PDF
Single Nucleotide Polymorphisms (SNPs) of URAT1 (rs7932775) and ABCG2 (rs3825016) on Chronic Kidney Disease Patients with Hyperuricemia 被引量:3
13
作者 Chunqing Li Qiong Tang +5 位作者 Hongwei Jiang Jing Wu Junlin Zhang Fenglai Yuan Yuan Du Haochang Du 《Chinese Medicine》 2018年第3期118-125,共8页
Background: More and more chronic kidney disease (CKD) patients are accompanied with hyperuricaemia. As is known, hyperuricaemia is an independent hazard of both cardiovascular diseases (CVD) and chronic kidney diseas... Background: More and more chronic kidney disease (CKD) patients are accompanied with hyperuricaemia. As is known, hyperuricaemia is an independent hazard of both cardiovascular diseases (CVD) and chronic kidney diseases. We aim at identifying Single Nucleotide Polymorphism (SNP) difference of hURAT1 (rs7932775) and ABCG2 (rs3825016) on CKD patient with hyperuricemia and/or gout. Methods: All forty-two CKD patients were divided into two groups: hyperuricemia, and control group. 24 hours urine sample and serum were prepared for testing biochemistry parameters. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method is used to analyze hURAT1 and ABCG2 single nucleotide polymorphisms in different groups. Results: 17 patients have CT SNP of hURAT1 (rs7932775) and 13 patients have CT SNP of ABCG2 (rs3825016) in hyperuricemia group, while only 5 persons and 6 persons have the same mutations in control group respectively. 7 patients have CT SNP of both hURAT1 (rs7932775) and ABCG2 (rs3825016) in hyperuricemia group, while only 2 persons have the same mutations in control group. CT mutation rates of hURAT1 (rs7932775) and ABCG2 (rs3825016) in hyperuricemia group were 60.7% (17/28) and 50% (13/28) respectively, higher than that of control group (35.7% (5/14) and 42.8% (6/14)). What is more, Double SNP mutations in both hURAT1 (rs7932775) and ABCG2 (rs3825016) in hyperuricemia group were 25% (7/28), higher than that of control group (14.2%, 2/14). Conclusion: There are higher mutation rates of CT SNP in hURAT1 (rs7932775) and/or ABCG2 (rs3825016) in hyperuricemia group. We can conclude that hyperuricemia is a high risk factor in progress of CKD, which is necessary to take measures of decreasing serum uric acid to delay CKD progress. 展开更多
关键词 HYPERURICEMIA Chronic Kidney Disease (CKD) Single NUCLEOTIDE Polymorphisms (SNP) human URATE Transport Protein (Hurat1) ATP Binding TRANSPORTER g Super Family (ABCg2)
下载PDF
血小板表达的HLA-G对人类T淋巴细胞白血病1型病毒蛋白Tax表达的影响
14
作者 张绍佳 赵桂增 +4 位作者 董航 李梦垚 于小佳 王李想 张晨光 《中国输血杂志》 CAS 2021年第10期1066-1069,共4页
目的探讨血小板表达的HLA-G对人类嗜T淋巴细胞1型病毒(HTLV-1)蛋白Tax表达的影响。方法从抗凝全血中分离血小板,运用流式细胞术检测血小板膜分子HLA-G;运用ELISA技术检测血小板裂解前后分泌型HLA-G分子含量;使用血小板裂解液(PL)培养HTL... 目的探讨血小板表达的HLA-G对人类嗜T淋巴细胞1型病毒(HTLV-1)蛋白Tax表达的影响。方法从抗凝全血中分离血小板,运用流式细胞术检测血小板膜分子HLA-G;运用ELISA技术检测血小板裂解前后分泌型HLA-G分子含量;使用血小板裂解液(PL)培养HTLV-1的人淋巴瘤细胞MT2,采用蛋白免疫印迹技术(WB)评价血小板表达的HLA-G对HTLV-1蛋白Tax表达的影响。结果血小板膜表面高表达膜型mHLA-G;血小板裂解后分泌型sHLA-G表达量(ng/mL)升高(15.73±1.01vs6.65±0.47),且随着血小板含量的升高而升高,呈剂量依赖效应;与胎牛血清相比,PL明显促进MT2细胞高表达HLA-G蛋白和HTLV-1病毒Tax蛋白,在PL中加入抗HLA-G抗体可有效抑制MT2细胞表达Tax、HLA-G蛋白。结论血小板上高表达的免疫耐受分子HLA-G可诱导人淋巴瘤细胞MT2高表达HTLV-1蛋白Tax,进而促进病毒感染。 展开更多
关键词 人类白细胞抗原g 人类T淋巴细胞白血病病毒1 血小板 免疫调节
下载PDF
Prokaryotic Expression and Purification of HIV-1 Vif and hAPOBEC3G, Preparation of Polyclonal Antibodies
15
作者 Lan LI Yi-shu YANG Ze-lin LI Yi ZENG 《Virologica Sinica》 SCIE CAS CSCD 2008年第3期173-182,共10页
To prepare HIV-1 Vif and hAPOBEC3G and to produce their antibodies, the full length gene fragment of HIV-1 vif was amplified by PCR from a plasmid of HIV-1 NL4.3 cDNA, and the APOBEC3G gene was obtained by RT-PCR from... To prepare HIV-1 Vif and hAPOBEC3G and to produce their antibodies, the full length gene fragment of HIV-1 vif was amplified by PCR from a plasmid of HIV-1 NL4.3 cDNA, and the APOBEC3G gene was obtained by RT-PCR from the total RNA of H9 cells. The resulting DNA construct was cloned into a prokaryotic expression vector (pET-32a). Recombinant pET-vif and pET-APOBEC3G were expressed respectively in Eserichia coli BL21 (DE3) as an insoluble protein. The vector also contained a six-histidine tag at the C-terminus for convenient purification and detection. To express and purify the HIV-1 Vif and hAPOBEC3G in E.coli cells, the accuracy of inserted gene and specificity of proteins were detected by the two enzyme digestion method, SDS-PAGE, and Western blotting. Rabbits were then immunized by Vif or APOBEC3G protein and serum samples were tested by indirect ELISA to determine the level of antibodies. Immunoenzyme and immunofluorescence assays were performed to identify the specificity of polyclonal antibodies. The titer of the anti-Vif antibodies was 1:204800, and that of the anti-APOBEC3G antibodies was 1:102400. Thus the antibodies could detect the antigen expression in the cells, demonstrating that fusion proteins with high purity and their corresponding polyclonal antibodies with high titer and specificity were achieved. 展开更多
关键词 human immunodeficiency virus type 1 (HIV-1 Viral infectivity factor hAPOBEC3g Protein purification Polyclonal antibody
下载PDF
黄体酮联合孕康口服液对习惯性流产患者血清性激素水平及sHLA-G、TGF-β_(1)、PIBF的影响 被引量:2
16
作者 柳君霞 冯治福 《反射疗法与康复医学》 2022年第16期33-35,共3页
目的探究黄体酮联合孕康口服液对习惯性流产患者血清性激素水平及可溶性人白细胞抗原(sHLA-G)、转化生长因子(TGF-β_(1))、孕激素诱导阻断因子(PTBF)的影响.方法选择本院2021年2月—2022年2月收治的82例习惯性流产患者,按照随机数字表... 目的探究黄体酮联合孕康口服液对习惯性流产患者血清性激素水平及可溶性人白细胞抗原(sHLA-G)、转化生长因子(TGF-β_(1))、孕激素诱导阻断因子(PTBF)的影响.方法选择本院2021年2月—2022年2月收治的82例习惯性流产患者,按照随机数字表法分为对照组(n=41)和观察组(n=41).对照组采用黄体酮治疗,观察组在此基础上采用孕康口服液治疗,均持续治疗2周.比较两组的血清性激素、sHLA-G、TGF-β_(1)、PTBF水平及不良反应发生情况.结果治疗前,两组的血清性激素、sHLA-G、TGF-β_(1)、PTBF水平比较,组间差异无统计学意义(P>0.05);治疗后,观察组的雌二醇、孕酮、卵泡刺激素、sHLA-G、TGF-β_(1)、PTBF水平均高于对照组,组间差异有统计学意义(P<0.05).观察组的不良反应发生率为12.20%,与对照组的9.76%比较,差异无统计学意义(P>0.05).结论黄体酮联合孕康口服液能够有效调节习惯性流产患者的性激素水平,促进sHLA-G、TGF-β_(1)、PTBF表达,安全可靠. 展开更多
关键词 习惯性流产 黄体酮 孕康口服液 性激素 可溶性人白细胞抗原 转化生长因子 孕激素诱导阻断因子
下载PDF
P16蛋白、HPV L-1壳蛋白在CIN和早期宫颈癌组织中的表达及其筛查价值 被引量:15
17
作者 项媛媛 王苗苗 +1 位作者 谢艳 袁智民 《中国妇幼健康研究》 2017年第7期778-780,共3页
目的分析P16蛋白、人乳头瘤病毒(HPV)L-1壳蛋白在宫颈上皮内瘤变(CIN)和宫颈癌中的表达及筛查价值。方法选取2014年1月至2016年6月淮安市妇幼保健院妇产科CIN和早期宫颈癌共50例患者,通过第二代杂交捕获法与免疫组化法分析P16蛋白、HPV ... 目的分析P16蛋白、人乳头瘤病毒(HPV)L-1壳蛋白在宫颈上皮内瘤变(CIN)和宫颈癌中的表达及筛查价值。方法选取2014年1月至2016年6月淮安市妇幼保健院妇产科CIN和早期宫颈癌共50例患者,通过第二代杂交捕获法与免疫组化法分析P16蛋白、HPV L-1壳蛋白在其组织中的表达。结果 P16蛋白在慢性宫颈炎(9.09%)、低度鳞状上皮内病变(52.94%)、高度鳞状上皮内病变(84.21%)及早期宫颈癌(100.00%)中的阳性表达率逐渐升高(χ2=45.38,P=0.00),人乳头瘤病毒L-1壳蛋白阳性表达率亦存在明显差异,分别是18.18%、35.29%、15.79%及0(χ2=12.59,P=0.00);随着病毒载量提高,P16蛋白与人乳头瘤病毒L-1壳蛋白阳性表达率均有所改变(χ2值分别为41.37、32.95,均P<0.01)。在慢性宫颈炎中,P16蛋白表达阳性率与高危型人乳头瘤病毒呈正相关关系(r=0.52,P=0.01);在低度鳞状上皮内病变中,P16蛋白、人乳头瘤病毒L-1壳蛋白阳性表达率与高危型人乳头瘤病毒均呈正相关关系(r值分别为0.58、0.33,均P<0.05);在高度鳞状上皮内病变及早期宫颈癌中,P16蛋白、人乳头瘤病毒L-1壳蛋白阳性表达率与高危型人乳头瘤病毒均未存在显著相关性(r值分别为0.12、0.26、0.62,均P>0.05)。结论 P16蛋白、人乳头瘤病毒L-1壳蛋白表达阳性可作为宫颈癌前病变出现的分子事件,在筛查CIN和早期宫颈癌中的价值较高,临床上值得应用和推广。 展开更多
关键词 高危型人乳头瘤病毒 P16蛋白 人乳头瘤病毒L-1壳蛋白 宫颈上皮内瘤变 宫颈癌
下载PDF
THE CONSTRUCTION OF HPV16-L1 RECOMBINANT PLASMID AND ITS EXPRESSION IN MAMMALIAN CELLS 被引量:1
18
作者 Sun Xiangle),Si Lüsheng,Cao Zansun Department of Obstetrics & Gynecology,Wang Yili,Liu Tianju,Guo Jianfen,Song Jianming Institute of Immunopathology, Xi′an Medical University, Xi′an 710061 《Journal of Pharmaceutical Analysis》 CAS 1999年第2期116-119,共4页
Infection with high risk human papillomavirus is regarded as the major risk factor in the development of cervical cancer. In this study, HPV16 L1 eukaryotic expression plasmids pcDNA LI were constructed, which were... Infection with high risk human papillomavirus is regarded as the major risk factor in the development of cervical cancer. In this study, HPV16 L1 eukaryotic expression plasmids pcDNA LI were constructed, which were transfected into mammalian cells Cos 7. The expression of HPV16 L1 in transfected cells were identified by in situ hybridization, immunospot and immunocytochemistry. HPV16 L1 mRNA transcription and L1 protein expression were found in recombinant plasmid transfected cells. This expression system will provide us with plentiful resource for HPV16 L1 immunological study and will be helpful for the design of HPV16 prophylactic vaccine. 展开更多
关键词 human papillomavirus type 16(hpv16 L1) eukaryotic expression cervical carcinoma
下载PDF
miR-1对HR HPV 16^+/18^+宫颈癌细胞周期相关蛋白的调控 被引量:1
19
作者 胡滔 洪颖 +7 位作者 陈红兰 常业飞 姜水 习杨彦彬 檀雅欣 李珊 刘光彩 吴晓虹 《昆明医科大学学报》 CAS 2018年第12期11-15,共5页
目的比较miR-1过表达及表达抑制后人宫颈癌细胞HPV16+Siha以及HPV18+Hela中细胞周期蛋白的表达影响,了解miR-1在HR HPV致瘤过程中的分子机制。方法构建miR-1过表达慢病毒载体及miR-1缺陷表达载体,转染高危型(HR) HPV16+/18+人宫颈癌细胞... 目的比较miR-1过表达及表达抑制后人宫颈癌细胞HPV16+Siha以及HPV18+Hela中细胞周期蛋白的表达影响,了解miR-1在HR HPV致瘤过程中的分子机制。方法构建miR-1过表达慢病毒载体及miR-1缺陷表达载体,转染高危型(HR) HPV16+/18+人宫颈癌细胞,运用Western blot方法对各组转染细胞中细胞周期蛋白Cyclin D1、Cyclin D2、Cyclin E的表达进行检测。结果 (1)成功获得miR-1过表达及表达抑制的人宫颈癌细胞株Hela和Siha;(2)与空白对照组相比,miR-1过表达及表达抑制后HR HPV16+/18+人宫颈癌细胞株中细胞周期蛋白出现了相应的表达改变。结论 miR-1在HR HPV+人宫颈癌中的致瘤性与其对细胞周期蛋白的表达调控密切相关。 展开更多
关键词 宫颈癌 高危型人乳头瘤病毒16/18型 MIR-1 细胞周期蛋白
下载PDF
Development of an in Vitro Assay to Evaluate the Biological Impact of 5G Technology on Human Skin—Shield Effect of a Tannin-Rich Plant Extract
20
作者 Katharina Kappler Franziska Wandrey +2 位作者 Jean-Eric Branka Stéphane Poigny Fred Zülli 《Journal of Cosmetics, Dermatological Sciences and Applications》 2022年第2期100-108,共9页
Background: The new 5G telecommunication technology has stirred concerns about potential negative effects on human health by radiofrequency electromagnetic fields. As to whether skin biology can be affected by 5G wave... Background: The new 5G telecommunication technology has stirred concerns about potential negative effects on human health by radiofrequency electromagnetic fields. As to whether skin biology can be affected by 5G waves has remained an unsolved challenge despite recent studies dealing with this issue. In particular, a strategy for rational design of an assay allowing to 1) reproducibly evaluate and decipher the 5G effects on skin as well as 2) test the potential protective effects of cosmetic active ingredients, has yet to be found. Here we describe an in vitro model of human normal keratinocytes irradiated by 5G waves and show their impact on two biomarkers of inflammatory stress, i.e. interleukin-1β (IL-1β) and reactive oxygen species (ROS) production. In addition, the capacity of a tannin-rich plant extract to protect against 5G impact is evaluated. Materials and Methods: In the first series of experiments, monolayers of human normal keratinocytes were irradiated or not (control) by 5G waves (3.5 MHz) in an anechoic chamber and were incubated at 37&#730;C for 24 hours. At the end of the incubation period, extracellular IL-1β and intracellular ROS were quantified using specific ELISA and colorimetric assays, respectively. In the second series of experiments, the effect of an overnight pre-incubation with increasing concentrations of a tannin-rich plant extract was evaluated. Additionally, we studied in a prospective way the expression of a set of 88 genes selected for their relevance to keratinocyte homeostasis, in relation to the 5G challenge as well as the protective effect of a tannin-rich plant extract. Results: 5G waves significantly increased IL-1β production by 48.4% (p β and ROS production. Finally, the expression of 47 genes was modified by 5G waves and/or by the tannin-rich plant extract. Conclusion: This is to our knowledge the first evaluation of the impact of 5G technology on inflammatory biomarkers of human normal skin cells. Here we provide an innovative and pertinent tool to screen for natural compounds with protective effects against 5G waves to develop cosmetic products shielding against the potentially deleterious effects of electromagnetic waves on human skin. 展开更多
关键词 5g waves human Normal Keratinocytes INFLAMMATION ROS INTERLEUKIN-1 mRNA
下载PDF
上一页 1 2 下一页 到第
使用帮助 返回顶部